Trial intelligence / Profile preview

Bepanthen Burn Relief Foam Spray New Formula for Thermic Erythema

NCT00839462Phase 2Completed

Sponsor
Bayer
Start
Sep 2007
Primary completion
Sep 2007
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Bepanthen Sensiderm in erythema, burn injury, sponsored by Bayer. Started Sep 2007; status: completed.

02

Drugs

Bepanthen Sensiderm
03

Conditions

erythemaburn injury

Beyond the preview

Go deeper on NCT00839462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00839462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call